NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding NeuroPace Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 39 | 41 | +2 |
| Shares | 11.2M | 18.0M | +6.82M (+61.0%) |
| Value | $177.4M | $181.5M | +$4.15M (+2.3%) |
New holders (6)
Institutions that held NeuroPace Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| KCK Ltd. | 5,621,111 | $56.7M | 40.01% |
| Revelation Capital Management, LLC | 666,540 | $6.72M | 6.48% |
| Point72 Asset Management, L.P. | 136,200 | $1.37M | 0.01% |
| Qube Research & Technologies Ltd | 19,086 | $192.0K | 0.00% |
| UBS Group AG | 3,703 | $38.0K | 0.00% |
| Point72 Hong Kong Ltd | 291 | $3.00K | 0.00% |
Sold out (4)
Institutions that held NeuroPace Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Sectoral Asset Management Inc | 444,572 | $7.05M |
| Amundi | 81,157 | $1.29M |
| Johnson & Johnson | 55,435 | $879.0K |
| Ghisallo Capital Management LLC | 15,000 | $238.0K |